We compared mean and median values of MBL level in a group of patients with hypopituitarism who were on appropriate replacement therapies (compensated hypopituitarism) versus patients being on inadequate replacement therapies (non-compensated hypopituitarism) (Figure 4). Here, MBL2 is linked to hypopituitarism.